The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The US Food and Drug Administration has approved a new, nonopioid pain medication for treating moderate to severe acute pain.